*Publicly traded
Funding for Spark, LivaNova and PINS is estimated, no data are available.
Galvani and BIOS have not announced launching indications. Some companies (Enteromedics, Biocontrol, and Transneuronix) have shut down, been acquired, or pivoted to new business areas